IO Biotech, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
IO Biotech, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2024.
  • IO Biotech, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $193K, a 10.3% increase year-over-year.
  • IO Biotech, Inc. annual Operating Lease, Payments for 2023 was $723K, a 72.6% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $193K +$18K +10.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $497K $175K +$78K +80.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $419K $149K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $117K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $56K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $97K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.